Katz A M
J Gen Physiol. 1967 Jul;50(6):Suppl:185-96. doi: 10.1085/jgp.50.6.185.
The heart's physiological performance, unlike that of skeletal muscle, is regulated primarily by variations in the contractile force developed by the individual myocardial fibers. In an attempt to identify the basis for the characteristic properties of myocardial contraction, the individual cardiac contractile proteins and their behavior in contractile models in vitro have been examined. The low shortening velocity of heart muscle appears to reflect the weak ATPase activity of cardiac myosin, but this enzymatic activity probably does not determine active state intensity. Quantification of the effects of Ca(++) upon cardiac actomyosin supports the view that myocardial contractility can be modified by changes in the amount of calcium released during excitation-contraction coupling. Exchange of intracellular K(+) with Na(+) derived from the extracellular space also could enhance myocardial contractility directly, as highly purified cardiac actomyosin is stimulated when K(+) is replaced by an equimolar amount of Na(+). On the other hand, cardiac glycosides and catecholamines, agents which greatly increase the contractility of the intact heart, were found to be without significant actions upon highly purified reconstituted cardiac actomyosin.
心脏的生理性能不同于骨骼肌,主要由单个心肌纤维产生的收缩力变化来调节。为了确定心肌收缩特性的基础,人们对单个心脏收缩蛋白及其在体外收缩模型中的行为进行了研究。心肌较低的缩短速度似乎反映了心肌肌球蛋白较弱的ATP酶活性,但这种酶活性可能并不决定活性状态强度。对Ca(++)对心肌肌动球蛋白作用的定量分析支持了这样一种观点,即心肌收缩力可通过兴奋-收缩偶联过程中释放的钙量的变化而改变。细胞内K(+)与来源于细胞外空间的Na(+)的交换也可直接增强心肌收缩力,因为当K(+)被等摩尔量的Na(+)取代时,高度纯化的心肌肌动球蛋白会受到刺激。另一方面,强心苷和儿茶酚胺这两种能显著增加完整心脏收缩力的药物,被发现对高度纯化的重组心肌肌动球蛋白没有明显作用。